P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827312568045142016 |
|---|---|
| author | F Muller F Gsottberger S Petkovic L Nitschke A Mackensen K Wendland |
| author_facet | F Muller F Gsottberger S Petkovic L Nitschke A Mackensen K Wendland |
| author_sort | F Muller |
| collection | DOAJ |
| first_indexed | 2024-04-24T21:45:31Z |
| format | Article |
| id | doaj.art-256197b53f0f4855b4366635e3eca8f4 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-04-24T21:45:31Z |
| publishDate | 2024-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-256197b53f0f4855b4366635e3eca8f42024-03-20T22:50:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262024-03-0112Suppl 110.1136/jitc-2024-ITOC10.62P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxinsF Muller0F Gsottberger1S Petkovic2L Nitschke3A Mackensen4K Wendland5University Hospital of Erlangen, Erlangen, Germany1University Hospital of Erlangen, Erlangen, GermanyUniversity Hospital of Erlangen, Erlangen, Germany2University of Erlangen, Erlangen, Germany1University Hospital of Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, Germany |
| spellingShingle | F Muller F Gsottberger S Petkovic L Nitschke A Mackensen K Wendland P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins Journal for ImmunoTherapy of Cancer |
| title | P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins |
| title_full | P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins |
| title_fullStr | P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins |
| title_full_unstemmed | P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins |
| title_short | P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins |
| title_sort | p12 08 targeting tumor reduced drug accessibility to counteract organ specific resistance to anti cd22 immunotoxins |
| work_keys_str_mv | AT fmuller p1208targetingtumorreduceddrugaccessibilitytocounteractorganspecificresistancetoanticd22immunotoxins AT fgsottberger p1208targetingtumorreduceddrugaccessibilitytocounteractorganspecificresistancetoanticd22immunotoxins AT spetkovic p1208targetingtumorreduceddrugaccessibilitytocounteractorganspecificresistancetoanticd22immunotoxins AT lnitschke p1208targetingtumorreduceddrugaccessibilitytocounteractorganspecificresistancetoanticd22immunotoxins AT amackensen p1208targetingtumorreduceddrugaccessibilitytocounteractorganspecificresistancetoanticd22immunotoxins AT kwendland p1208targetingtumorreduceddrugaccessibilitytocounteractorganspecificresistancetoanticd22immunotoxins |